BNP Paribas Financial Markets
PHIO icon

BNP Paribas Financial Markets’s Phio Pharmaceuticals PHIO Stock Holding History

BNP Paribas Financial Markets’s Portfolio PHIO Stock Details PHIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-413
Closed -$1.02K – 5902
2025
Q3 		$1.02K Buy
+413
New +$940 ﹤0.01% 5233

Other funds holding PHIO

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Cetera Investment Advisers
Cetera Investment Advisers Schaumburg, Illinois $110B AUM 26.29% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
DS
DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
SG
StoneX Group New York $2.48B AUM 33.54% 1-Year Est. Return
RSWM
Robertson Stephens Wealth Management San Francisco, California $4.06B AUM 32.22% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

BNP Paribas Financial Markets's PHIO Position: Q4 2025 in Review

BNP Paribas Financial Markets sold out of Phio Pharmaceuticals (PHIO) in Q4 2025, closing a stake of 413 shares — an estimated $1.02K sold.

BNP Paribas Financial Markets first reported a position in PHIO in Q3 2025 and held it in 1 quarter. The position peaked at $1.02K in Q3 2025. 17 funds tracked by Wall St. Rank hold PHIO as of Q4 2025.

  • BNP Paribas Financial Markets reported no remaining Phio Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • BNP Paribas Financial Markets sold 413 Phio Pharmaceuticals shares in Q4 2025, an estimated $1.02K.
  • BNP Paribas Financial Markets first reported a position in Phio Pharmaceuticals in Q3 2025 and held it in 1 quarter.
  • BNP Paribas Financial Markets's Phio Pharmaceuticals position peaked at $1.02K in Q3 2025.
  • 17 funds tracked by Wall St. Rank held Phio Pharmaceuticals as of Q4 2025.

Based on BNP Paribas Financial Markets's 13F filing for Q4 2025, filed 10 Feb 2026.